Breast Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Breast Cancer stocks.

Breast Cancer Stocks Recent News

Date Stock Title
Jul 11 ATOS Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
Jul 11 OCX MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
Jul 11 AZN The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Jul 11 AZN Three UK Exchange Stocks Estimated To Be Valued Up To 39.2% Below Intrinsic Worth
Jul 10 AZN Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
Jul 9 AZN AstraZeneca PLC (AZN): Is This FTSE Dividend Stock a Good Buy Right Now?
Jul 8 SLS SELLAS' SLS009 granted orphan drug designation by EMA for acute myeloid leukemia treatment
Jul 8 SLS SELLAS Receives European Medicines Agency Orphan Drug Designation for SLS009 for the Treatment of Acute Myeloid Leukemia
Jul 8 AZN The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Jul 5 ACHV With 64% ownership of the shares, Achieve Life Sciences, Inc. (NASDAQ:ACHV) is heavily dominated by institutional owners
Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Breast Cancer

Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior history of breast cancer, and family history. About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments are most likely to be effective.The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm. A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age, and the organization recommends screening every two years in women 50 to 74 years old. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it. Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age. Survival rates in the developed world are high, with between 80% and 90% of those in England and the United States alive for at least 5 years. In developing countries survival rates are poorer. Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. In 2012 it resulted in 1.68 million new cases and 522,000 deaths. It is more common in developed countries and is more than 100 times more common in women than in men.

Browse All Tags